Cell factories for sustainable production of valuable chemicals – the pivotal role of Saccharomyces cerevisiae
DOI:
https://doi.org/10.21814/jus.5268Keywords:
Green economy, cell factory, biotechnology, Saccharomyces cerevisiaeAbstract
The green economy aims to substitute polluting chemicals and processes with sustainable counterparts deriving from microbial cell factories that provide catalytic specificity and efficient conversions. In this manuscript, we explore how the bio-based production of chemicals enables the production of valuable molecules while reducing contemporary society's dependence on fossil fuels thereby alleviating part of the environmental burden. We discuss several emerging bio-based solutions and their impacts, with a particular focus on the potential of the yeast Saccharomyces cerevisiae in leading industrial microbial fermentation. Yeast remains a versatile, productive, and robust platform for producing metabolites and recombinant proteins.
References
J. Nielsen, C. B. Tillegreen and D. Petranovic, “Innovation trends in industrial biotechnology,” Trends Biotechnol., vol. 40, no. 10, pp. 1160–1172, Oct. 2022, doi: 10.1016/j.tibtech.2022.03.007.
M. M. Hanczyc, “Engineering Life: A Review of Synthetic Biology,” Artif. Life, vol. 26, no. 2, pp. 260–273, Apr. 2020, doi: 10.1162/artl_a_00318.
J. Nielsen and J. D. Keasling, “Engineering Cellular Metabolism,” Cell, vol. 164, no. 6, pp. 1185–1197, Mar. 2016, doi: 10.1016/j.cell.2016.02.004.
D. Romero-Suarez, J. D. Keasling, and M. K. Jensen, “Supplying plant natural products by yeast cell factories,” Current Opinion in Green and Sustainable Chemistry, vol. 33, p. 100567, Feb. 2022, doi: 10.1016/j.cogsc.2021.100567.
T. Perrot, J. Marc, E. Lezin, N. Papon, S. Besseau, and V. Courdavault, “Emerging trends in production of plant natural products and new-to-nature biopharmaceuticals in yeast,” Curr. Opin. Biotechnol., vol. 87, p. 103098, Mar. 2024, doi: 10.1016/j.copbio.2024.103098.
E. Barbier, “How is the Global Green New Deal going?,” Nature, vol. 464, no. 7290, pp. 832–833, Apr. 2010, doi: 10.1038/464832a.
P. Söderholm, “The green economy transition: the challenges of technological change for sustainability,” Sustainable Earth, vol. 3, no. 1, pp. 1–11, Jun. 2020, doi: 10.1186/s42055-020-00029-y.
United Nations, “Transforming our world: The 2030 agenda for sustainable development,” United Nations, Oct. 2015. Accessed: Apr. 27, 2023. [Online]. Available: https://sdgs.un.org/2030agenda
J. Lelieveld, K. Klingmüller, A. Pozzer, R. T. Burnett, A. Haines, and V. Ramanathan, “Effects of fossil fuel and total anthropogenic emission removal on public health and climate,” Proc. Natl. Acad. Sci. U. S. A., vol. 116, no. 15, pp. 7192–7197, Apr. 2019, doi: 10.1073/pnas.1819989116.
FAO, IFAD, UNICEF, WFP, and WHO, “The State of Food Security and Nutrition in the World 2022. Repurposing food and agricultural policies to make healthy diets more affordable,” Food and Agriculture Organization, 2022. doi: 10.4060/cc0639en.
C. Baumeister and L. Kilian, “Forty Years of Oil Price Fluctuations: Why the Price of Oil May Still Surprise Us,” J. Econ. Perspect., vol. 30, no. 1, pp. 139–160, Feb. 2016, doi: 10.1257/jep.30.1.139.
S. Gross, “Why are fossil fuels so hard to quit?,” Brookings. Accessed: Apr. 27, 2023. [Online]. Available: https://www.brookings.edu/essay/why-are-fossil-fuels-so-hard-to-quit/
H. Ritchie, M. Roser, and P. Rosado, “Energy,” Our World in Data, Oct. 2022, Accessed: May 02, 2023. [Online]. Available: https://ourworldindata.org/energy
V. Inyang, O. T. Laseinde, and G. M. Kanakana, “Techniques and applications of lignocellulose biomass sources as transport fuels and other bioproducts,” Int J Low-Carbon Tech, vol. 17, pp. 900–909, Jul. 2022, doi: 10.1093/ijlct/ctac068.
A. Devi, S. Bajar, H. Kour, R. Kothari, D. Pant, and A. Singh, “Lignocellulosic Biomass Valorization for Bioethanol Production: a Circular Bioeconomy Approach,” Bioenergy Res., vol. 15, no. 4, pp. 1820–1841, Feb. 2022, doi: 10.1007/s12155-022-10401-9.
Y. Shen, L. Jarboe, R. Brown, and Z. Wen, “A thermochemical-biochemical hybrid processing of lignocellulosic biomass for producing fuels and chemicals,” Biotechnol. Adv., vol. 33, no. 8, pp. 1799–1813, Dec. 2015, doi: 10.1016/j.biotechadv.2015.10.006.
L. Lange et al., “Developing a Sustainable and Circular Bio-Based Economy in EU: By Partnering Across Sectors, Upscaling and Using New Knowledge Faster, and For the Benefit of Climate, Environment & Biodiversity, and People & Business,” Front Bioeng Biotechnol, vol. 8, p. 619066, 2020, doi: 10.3389/fbioe.2020.619066.
R. Pallardy, “Lignocellulose: how nature’s wonder material could help the energy transition,” World Economic Forum. Accessed: May 02, 2023. [Online]. Available: https://www.weforum.org/agenda/2021/10/lignocellulose-how-natures-miracle-material-could-help-the-energy-transition/
Neste, “Future raw materials,” Neste worldwide. Accessed: May 04, 2023. [Online]. Available: https://www.neste.com/products/all-products/raw-materials/future-raw-materials
D. Mattanovich, M. Sauer, and B. Gasser, “Yeast biotechnology: teaching the old dog new tricks,” Microbial cell factories, vol. 13, no. 1. p. 34, Mar. 06, 2014. doi: 10.1186/1475-2859-13-34.
B. C. Behera, “Citric acid from Aspergillus niger: a comprehensive overview,” Crit. Rev. Microbiol., vol. 46, no. 6, pp. 727–749, Nov. 2020, doi: 10.1080/1040841X.2020.1828815.
N. A. Baeshen et al., “Cell factories for insulin production,” Microb. Cell Fact., vol. 13, p. 141, Oct. 2014, doi: 10.1186/s12934-014-0141-0.
S. Galanie, K. Thodey, I. J. Trenchard, M. Filsinger Interrante, and C. D. Smolke, “Complete biosynthesis of opioids in yeast,” Science, vol. 349, no. 6252, pp. 1095–1100, Sep. 2015, doi: 10.1126/science.aac9373.
S. Choi, C. W. Song, J. H. Shin, and S. Y. Lee, “Biorefineries for the production of top building block chemicals and their derivatives,” Metab. Eng., vol. 28, pp. 223–239, Mar. 2015, doi: 10.1016/j.ymben.2014.12.007.
J. J. Bozell and G. R. Petersen, “Technology development for the production of biobased products from biorefinery carbohydrates—the US Department of Energy’s ‘Top 10’ revisited,” Green Chem., vol. 12, no. 4, pp. 539–554, Apr. 2010, doi: 10.1039/B922014C.
D.-K. Ro et al., “Production of the antimalarial drug precursor artemisinic acid in engineered yeast,” Nature, vol. 440, no. 7086, pp. 940–943, Apr. 2006, doi: 10.1038/nature04640.
T. Wirth, R. K. Allemann, and S. Webster, “Looking for cheaper routes to malaria medicines,” Chemical & Engineering News. Accessed: Apr. 12, 2023. [Online]. Available: https://cen.acs.org/articles/96/i11/Looking-cheaper-routes-malaria-medicines.html
C. A. Voigt, “Synthetic biology 2020-2030: six commercially-available products that are changing our world,” Nat. Commun., vol. 11, no. 1, p. 6379, Dec. 2020, doi: 10.1038/s41467-020-20122-2.
R. Varadan et al., “Ground meat replicas,” USPTO, vol. 10172380, Jan. 2019, Accessed: Apr. 12, 2023. [Online]. Available: https://patentimages.storage.googleapis.com/fe/75/93/78a0e83e61efc2/US10172380.pdf
H. Ritchie and M. Roser, “Land Use,” Our World in Data, Nov. 2013, Accessed: Apr. 27, 2023. [Online]. Available: https://ourworldindata.org/land-use
K. Temme et al., “Methods and compositions for improving plant traits,” World Intellectual Property Organization, vol. 2018132774:A1, Jul. 2018, [Online]. Available: https://patentimages.storage.googleapis.com/ff/4b/f9/ece1903b5cc6f6/WO2018132774A1.pdf
Asahi Kasei Corp. Genomatica, Inc., “Genomatica and Asahi Kasei Partner on Renewably-Sourced Nylon 6,6,” Asahi Kasei. Accessed: Jun. 08, 2024. [Online]. Available: https://www.asahi-kasei.com/news/2021/e220316_2.html
AMSilk, “AMSilk and 21st.BIO announce partnership to accelerate the production of advanced materials made from spider silk-based proteins,” AMSilk. Accessed: Jun. 08, 2024. [Online]. Available: https://www.amsilk.com/amsilk-and-21st-bio-announce-partnership-to-accelerate-the-production-of-advanced-materials-made-from-spider-silk-based-proteins/
C. K. Savile et al., “Biocatalytic asymmetric synthesis of chiral amines from ketones applied to sitagliptin manufacture,” Science, vol. 329, no. 5989, pp. 305–309, Jul. 2010, doi: 10.1126/science.1188934.
A. Zoombelt, S. M. Edgar, and A. A. Albarran, “Optically transparent polyimides,” World Intellectual Property Organization, vol. 2020068276:A2, Apr. 2020, [Online]. Available: https://patentimages.storage.googleapis.com/ea/e7/ae/3303f7f006f4cf/WO2020068276A2.pdf
M. C. O’Leary et al., “FDA Approval Summary: Tisagenlecleucel for Treatment of Patients with Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia,” Clin. Cancer Res., vol. 25, no. 4, pp. 1142–1146, Feb. 2019, doi: 10.1158/1078-0432.CCR-18-2035.
Q. Shan, Z. Demorest, and J. Presnail, “Increased of saturated fat in soybean,” World Intellectual Property Organization, vol. 2021155376:A1, Aug. 2021, [Online]. Available: https://patentimages.storage.googleapis.com/e7/16/a5/52e7d1ea90ce44/WO2021155376A1.pdf
R. Pandya, P. Gandhi, S. Ji, D. Beauchamp, and L. Hom, “Food compositions comprising one or both of recombinant beta-lactoglobulin protein and recombinant alpha-lactalbumin protein,” USPTO, vol. 9924728, Mar. 2018, [Online]. Available: https://patentimages.storage.googleapis.com/b5/34/2f/e236c08fc93f6c/US9924728.pdf
Mycorena, “Mycorena partners with leading European companies to commercially launch fungi-stabilised fat mycoleinTM,” Mycorena. Accessed: May 14, 2023. [Online]. Available: https://mycorena.com/mycotalks
T. Ghi et al., “Why the bio-based materials market is finally poised for growth,” Arthur Little. Accessed: May 14, 2023. [Online]. Available: https://www.adlittle.com/en/insights/prism/why-bio-based-materials-market-finally-poised-growth
Precedence Research, “Biotechnology Market Size, Share, Growth, Forecast 2023-2030,” Precedence Research, Dec. 2022. Accessed: May 14, 2023. [Online]. Available: https://www.precedenceresearch.com/biotechnology-market
B. Buntz, “The 50 best-selling pharmaceuticals of 2022: COVID-19 vaccines poised to take a step back,” Drug Discovery and Development. Accessed: Apr. 23, 2023. [Online]. Available: https://www.drugdiscoverytrends.com/50-of-2022s-best-selling-pharmaceuticals/
C. Geijer, R. Ledesma-Amaro, and E. Tomás-Pejó, “Unraveling the potential of non-conventional yeasts in biotechnology,” FEMS Yeast Res., vol. 22, no. 1, Jan. 2022, doi: 10.1093/femsyr/foab071.
M. L. A. Jansen et al., “Saccharomyces cerevisiae strains for second-generation ethanol production: from academic exploration to industrial implementation,” FEMS Yeast Res., vol. 17, no. 5, Aug. 2017, doi: 10.1093/femsyr/fox044.
Braskem, “Braskem and Lummus partnership: the next chapter for Green Ethylene technology.” Accessed: Apr. 17, 2023. [Online]. Available: https://www.braskem.com.br/usa/news-detail/braskem-and-lummus-partnership-the-next-chapter-for-green-ethylene-technology
Renewable Fuels Association, “Annual Ethanol Production,” Annual Ethanol Production. Accessed: Apr. 17, 2023. [Online]. Available: https://ethanolrfa.org/markets-and-statistics/annual-ethanol-production
J. Qin et al., “Engineering yeast metabolism for the discovery and production of polyamines and polyamine analogues,” Nature Catalysis, vol. 4, no. 6, pp. 498–509, Jun. 2021, doi: 10.1038/s41929-021-00631-z.
J. Nielsen, “Production of biopharmaceutical proteins by yeast: advances through metabolic engineering,” Bioengineered, vol. 4, no. 4, pp. 207–211, Jul. 2013, doi: 10.4161/bioe.22856.
S. K. Nandy and R. K. Srivastava, “A review on sustainable yeast biotechnological processes and applications,” Microbiol. Res., vol. 207, pp. 83–90, Mar. 2018, doi: 10.1016/j.micres.2017.11.013.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Paulo César Silva, Björn Johansson
This work is licensed under a Creative Commons Attribution 4.0 International License.
Journal Uminho Science (JUS) magazine, in order to protect the interests of the authors of the articles and also their own, follows the terms and conditions of "Creative Commons Atribution 4.0 International Public License" whose credit belongs to “Creative Commons” (creativecommons.org).
By agreeing to the terms of this license you are granting us your permission to use your item under the terms and conditions specified in this license.
"By exercising the Licensed Rights (defined below), You accept and agree to be bound by the terms and conditions of this Creative Commons Attribution 4.0 International Public License ("Public License"). To the extent this Public License may be interpreted as a contract, You are granted the Licensed Rights in consideration of Your acceptance of these terms and conditions, and the Licensor grants You such rights in consideration of benefits the Licensor receives from making the Licensed Material available under these terms and conditions.
Section 1 – Definitions.
Adapted Material means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image.
Adapter's License means the license You apply to Your Copyright and Similar Rights in Your contributions to Adapted Material in accordance with the terms and conditions of this Public License.
Copyright and Similar Rights means copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section 2(b)(1)-(2) are not Copyright and Similar Rights.
Effective Technological Measures means those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements.
Exceptions and Limitations means fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material.
Licensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License.
Licensed Rights means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license.
Licensor means the individual(s) or entity(ies) granting rights under this Public License.
Share means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them.
Sui Generis Database Rights means rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world.
You means the individual or entity exercising the Licensed Rights under this Public License. Your has a corresponding meaning.
Section 2 – Scope.
License grant.
Subject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to:
- Reproduce and Share the Licensed Material, in whole or in part; and
- Produce, reproduce, and Share Adapted Material.
Exceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions.
Term. The term of this Public License is specified in Section 6(a).
Media and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section 2(a)(4) never produces Adapted Material.
Downstream recipients.
Offer from the Licensor – Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License.
No downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material.
No endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section 3(a)(1)(A)(i).
Other rights.
Moral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise.
Patent and trademark rights are not licensed under this Public License.
To the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties.
Section 3 – License Conditions.
Your exercise of the Licensed Rights is expressly made subject to the following conditions.
Attribution.
If You Share the Licensed Material (including in modified form), You must retain the following if it is supplied by the Licensor with the Licensed Material:
- Identification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated);
- A copyright notice;
- A notice that refers to this Public License;
- A notice that refers to the disclaimer of warranties;
- A URI or hyperlink to the Licensed Material to the extent reasonably practicable;
- Indicate if You modified the Licensed Material and retain an indication of any previous modifications; and
- Indicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License.
You may satisfy the conditions in Section 3(a)(1) in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information.
If requested by the Licensor, You must remove any of the information required by Section 3(a)(1)(A) to the extent reasonably practicable.
If You Share Adapted Material You produce, the Adapter's License You apply must not prevent recipients of the Adapted Material from complying with this Public License.
Section 4 – Sui Generis Database Rights.
Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:
- For the avoidance of doubt, Section 2(a)(1) grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database;
- If You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material;
- You must comply with the conditions in Section 3(a) if You Share all or a substantial portion of the contents of the database.
For the avoidance of doubt, this Section 4 supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights.
Section 5 – Disclaimer of Warranties and Limitation of Liability.
Unless otherwise separately undertaken by the Licensor, to the extent possible, the Licensor offers the Licensed Material as-is and as-available, and makes no representations or warranties of any kind concerning the Licensed Material, whether express, implied, statutory, or other. This includes, without limitation, warranties of title, merchantability, fitness for a particular purpose, non-infringement, absence of latent or other defects, accuracy, or the presence or absence of errors, whether or not known or discoverable. Where disclaimers of warranties are not allowed in full or in part, this disclaimer may not apply to You.
To the extent possible, in no event will the Licensor be liable to You on any legal theory (including, without limitation, negligence) or otherwise for any direct, special, indirect, incidental, consequential, punitive, exemplary, or other losses, costs, expenses, or damages arising out of this Public License or use of the Licensed Material, even if the Licensor has been advised of the possibility of such losses, costs, expenses, or damages. Where a limitation of liability is not allowed in full or in part, this limitation may not apply to You.
The disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.
Section 6 – Term and Termination.
This Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically.
Where Your right to use the Licensed Material has terminated under Section 6(a), it reinstates:
- Automatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation;
- Or, upon express reinstatement by the Licensor.
For the avoidance of doubt, this Section 6(b) does not affect any right the Licensor may have to seek remedies for Your violations of this Public License.
For the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License.
Sections 1, 5, 6, 7, and 8 survive termination of this Public License.
Section 7 – Other Terms and Conditions.
The Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed.
Any arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License.
Section 8 – Interpretation.
For the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License.
To the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions.
No term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor.
Nothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority."
